Loading song details...
GDF2025 D2S08 Common Clinical Deficiencies In ANDAs Containing Comparative Endpoint Studies
No description available.
MP3 Download
Video Download
Related Songs
18:21
GDF2025 D2S08 Common Clinical Deficiencies In ANDAs Containing Comparative Endpoint Studies
14:47
GDF2025 D2S18 Common Bioequivalence Information Requests Tips For Facilitating The Review Process
17:11
GDF2025 D2S12 Common Quality Major Deficiencies In Abbreviated New Drug Applications ANDAs
20:06
GDF2025 D1S05 Request For Reconsideration Process Overview And Best Practices FDA Evaluation
14:19
GDF2025 D2S07 Common Bioequivalence Deficiencies In Abbreviated New Drug Applications
17:55
GDF2025 D1S19 Common Discrepancies Observed On The Form 356h With ANDA Submission
17:53
GDF2025 D1S08 Best Practices For Generic Drug Labeling
5:23
GDF2025 D2S20 Closing Remarks
18:51
GDF2025 D2S11 Common Deficiencies In Drug Master Files DMFs
21:08
GDF2025 D2S01 General Quality Considerations Of Drug Products Labeled For Alternate Dosing
22:26
GDF2025 D1S07 Questions Panel Discussion Session One
17:50
GDF2025 D1S12 Considerations When Submitting Proposed Excipient Levels In IIG
0
Round 1 FPO 2026 Swedish Open
17:30
GDF2025 D2S04 Questions Panel Discussion Session One
14:38
GDF2025 D1S11 Questions Panel Discussion Session Two
14:38
GDF2025 D2S03 Bioequivalence Approaches For Nitrosamine Impacted ANDA Applications Case Studies
19:17
GDF2025 D1S06 RFR Under GDUFA III Overview And Experience From BE Perspectives
17:32
GDF2025 D1S09 Project Managing Drug Assessors Under GDUFA III Regulations
20:05